GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Kedudukan dalam Saham
#3636
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Harga Saham
$27.56
Modal Pasaran
$4.67B
Perubahan (1 hari)
-2.65%
Perubahan (1 tahun)
-11.55%
Negara
IN
Perdagangan GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategori
Healthcare
Margin Operasi untuk GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Margin Operasi pada October 2026 TTM: 32.54%
Menurut laporan kewangan dan harga saham terkini GlaxoSmithKline Pharmaceuticals Limited, margin operasi semasa (TTM) ialah 32.54%. Pada akhir 2024, margin operasi syarikat ialah 39.38%.
Sejarah Margin Operasi untuk GlaxoSmithKline Pharmaceuticals Limited dari 2004 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Ubah |
|---|---|---|
| 2026 (TTM) | 32.54% | -25.20% |
| 2025 | 43.50% | 10.46% |
| 2024 | 39.38% | 69.60% |
| 2023 | 23.22% | 8.10% |
| 2022 | 21.48% | 19.27% |
| 2021 | 18.01% | 6.88% |
| 2020 | 16.85% | -19.30% |
| 2019 | 20.88% | 14.22% |
| 2018 | 18.28% | 35.41% |
| 2017 | 13.50% | -19.59% |
| 2016 | 16.79% | -9.34% |
| 2015 | 18.52% | -8.95% |
| 2013 | 20.34% | -32.47% |
| 2012 | 30.12% | -22.75% |
| 2011 | 38.99% | -3.78% |
| 2010 | 40.52% | 1.55% |
| 2009 | 39.90% | -3.62% |
| 2008 | 41.40% | 6.10% |
| 2007 | 39.02% | 8.99% |
| 2006 | 35.80% | 11.32% |
| 2005 | 32.16% | 5.96% |
| 2004 | 30.35% | 0.00% |
Margin Operasi untuk syarikat serupa atau pesaing
| Syarikat | Margin Operasi | Perbezaan Margin Operasi | Negara |
|---|---|---|---|
| 49.72% | -98.47% |
US
|
|
| 25.70% | -99.21% |
US
|
|
| 29.32% | -99.10% |
US
|
|
| 16.65% | -99.49% |
US
|
|
| 26.59% | -99.18% |
CH
|
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.